Enhance your clinical development process with Tempus’ CDx platform

Learn how A2 Biotherapeutics is making progress on a breakthrough cell therapy using HLA-LOH (human leukocyte antigen-loss of heterozygosity) as a biomarker, using Tempus’ comprehensive immunotherapy platform.

Apr 16, 2024
Life Sciences
Case Study

Related content

Simple white graphic of a single sheet of paper or document, slightly angled.Article
Person works on computer with abstract digital code and data patterns overlayed.

Constructing clinical timelines with line of therapy

Life Sciences
Simple white graphic of a single sheet of paper or document, slightly angled.Article
Light background with faint, pixelated letters resembling DNA or digital code.

Designing smarter trials: A new model for clinical development

2026-04-28
Life Sciences
Simple white graphic of a single sheet of paper or document, slightly angled.Article
Abstract image with blurred geometric cubes and DNA sequences on a light background.

How biotechs can build a data-driven R&D strategy

2026-04-27
Life Sciences